Glycopyrrolate Injection
Product Images NDC 0641-6213
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0641-6213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Syringe Image (Glycopyrrolate Injection Usp Syringe 2)
Figure 2 (Glycopyrrolate Injection Usp Syringe 3)
Glycopyrrolate 1ml Syringe Label (Glycopyrrolate Injection Usp Syringe 4)
Glycopyrrolate 1 mL Carton (Glycopyrrolate Injection Usp Syringe 5)
This text provides details about a medication with the NDC code 0641-6212-10, intended for intramuscular or intravenous use. The medication is presented in 0.2g glycopyrrolate, with water for injection and hydrochloric acid/sodium hydroxide for pH adjustment. The recommended dosage information is available with the prescription. The medication is stored at a specified temperature range and should be discarded if unused. It is manufactured by Hikma Pharmaceuticals USA Inc., located in Berely Heights, NJ 07322. The pre-filled syringes are single-dose and preservative-free.*
Glycopyrrolate 2 mL Syringe Label (Glycopyrrolate Injection Usp Syringe 6)
Glycopyrrolate 2 mL Carton (Glycopyrrolate Injection Usp Syringe 7)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.